<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35219855</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>07</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1095-953X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>167</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>Neurobiology of disease</Title>
          <ISOAbbreviation>Neurobiol Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Na<sub>V</sub>1.1 haploinsufficiency impairs glutamatergic and GABAergic neuron function in the thalamus.</ArticleTitle>
        <Pagination>
          <StartPage>105672</StartPage>
          <MedlinePgn>105672</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nbd.2022.105672</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0969-9961(22)00063-8</ELocationID>
        <Abstract>
          <AbstractText>Thalamocortical network dysfunction contributes to seizures and sleep deficits in Dravet syndrome (DS), an infantile epileptic encephalopathy, but the underlying molecular and cellular mechanisms remain elusive. DS is primarily caused by mutations in the SCN1A gene encoding the voltage-gated sodium channel Na<sub>V</sub>1.1, which is highly expressed in GABAergic reticular thalamus (nRT) neurons as well as glutamatergic thalamocortical neurons. We hypothesized that Na<sub>V</sub>1.1 haploinsufficiency alters somatosensory corticothalamic circuit function through both intrinsic and synaptic mechanisms in nRT and thalamocortical neurons. Using Scn1a heterozygous mice of both sexes aged P25-P30, we discovered reduced excitability of nRT neurons and thalamocortical neurons in the ventral posterolateral (VPL) thalamus, while thalamocortical ventral posteromedial (VPM) neurons exhibited enhanced excitability. Na<sub>V</sub>1.1 haploinsufficiency enhanced GABAergic synaptic input and reduced glutamatergic input to VPL neurons, but not VPM neurons. In addition, glutamatergic input to nRT neurons was reduced in Scn1a heterozygous mice. These findings introduce alterations in glutamatergic synapse function and aberrant glutamatergic neuron excitability in the thalamus as disease mechanisms in DS, which has been widely considered a disease of GABAergic neurons. This work reveals additional complexity that expands current models of thalamic dysfunction in DS and identifies new components of corticothalamic circuitry as potential therapeutic targets.</AbstractText>
          <CopyrightInformation>Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Studtmann</LastName>
            <ForeName>Carleigh</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Neurobiology Research, Fralin Biomedical Research Institute at VTC, Virginia Tech, Roanoke, VA, USA; Graduate Program in Translational Biology, Medicine, and Health, Virginia Tech, Blacksburg, VA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ladislav</LastName>
            <ForeName>Marek</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Neurobiology Research, Fralin Biomedical Research Institute at VTC, Virginia Tech, Roanoke, VA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Topolski</LastName>
            <ForeName>Mackenzie A</ForeName>
            <Initials>MA</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Neurobiology Research, Fralin Biomedical Research Institute at VTC, Virginia Tech, Roanoke, VA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Safari</LastName>
            <ForeName>Mona</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Neurobiology Research, Fralin Biomedical Research Institute at VTC, Virginia Tech, Roanoke, VA, USA; Graduate Program in Translational Biology, Medicine, and Health, Virginia Tech, Blacksburg, VA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Swanger</LastName>
            <ForeName>Sharon A</ForeName>
            <Initials>SA</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Neurobiology Research, Fralin Biomedical Research Institute at VTC, Virginia Tech, Roanoke, VA, USA; Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA, USA; Department of Internal Medicine, Virginia Tech Carilion School of Medicine, Roanoke, VA, USA. Electronic address: saswanger@vtc.vt.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 NS105804</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>02</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Neurobiol Dis</MedlineTA>
        <NlmUniqueID>9500169</NlmUniqueID>
        <ISSNLinking>0969-9961</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D062550">NAV1.1 Voltage-Gated Sodium Channel</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C568249">Scn1a protein, mouse</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004831" MajorTopicYN="Y">Epilepsies, Myoclonic</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059330" MajorTopicYN="Y">GABAergic Neurons</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057895" MajorTopicYN="N">Haploinsufficiency</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062550" MajorTopicYN="N">NAV1.1 Voltage-Gated Sodium Channel</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013788" MajorTopicYN="N">Thalamus</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Dravet syndrome</Keyword>
        <Keyword MajorTopicYN="Y">Excitability</Keyword>
        <Keyword MajorTopicYN="Y">GABAergic</Keyword>
        <Keyword MajorTopicYN="Y">Glutamatergic</Keyword>
        <Keyword MajorTopicYN="Y">Na(V)1.1</Keyword>
        <Keyword MajorTopicYN="Y">Reticular thalamus</Keyword>
        <Keyword MajorTopicYN="Y">SCN1A</Keyword>
        <Keyword MajorTopicYN="Y">Somatosensory thalamus</Keyword>
        <Keyword MajorTopicYN="Y">Synaptic transmission</Keyword>
        <Keyword MajorTopicYN="Y">Thalamocortical neuron</Keyword>
      </KeywordList>
      <CoiStatement>Declaration of interests. None</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2023</Year>
          <Month>6</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>27</Day>
          <Hour>20</Hour>
          <Minute>29</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35219855</ArticleId>
        <ArticleId IdType="mid">NIHMS1785676</ArticleId>
        <ArticleId IdType="pmc">PMC8957548</ArticleId>
        <ArticleId IdType="doi">10.1016/j.nbd.2022.105672</ArticleId>
        <ArticleId IdType="pii">S0969-9961(22)00063-8</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Ab Aziz CB, and Ahmad AH (2006). The role of the thalamus in modulating pain. Malays J Med Sci
13, 11–18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3349479</ArticleId>
            <ArticleId IdType="pubmed">22589599</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Acker TM, Yuan H, Hansen KB, Vance KM, Ogden KK, Jensen HS, Burger PB, Mullasseril P, Snyder JP, Liotta DC, and Traynelis SF (2011). Mechanism for noncompetitive inhibition by novel GluN2C/D N-methyl-D-aspartate receptor subunit-selective modulators. Mol Pharmacol
80, 782–795. 10.1124/mol.111.073239.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1124/mol.111.073239</ArticleId>
            <ArticleId IdType="pmc">PMC3198917</ArticleId>
            <ArticleId IdType="pubmed">21807990</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Almog Y, Fadila S, Brusel M, Mavashov A, Anderson K, and Rubinstein M (2021). Developmental alterations in firing properties of hippocampal CA1 inhibitory and excitatory neurons in a mouse model of Dravet syndrome. Neurobiol Dis
148, 105209. 10.1016/j.nbd.2020.105209.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.nbd.2020.105209</ArticleId>
            <ArticleId IdType="pubmed">33271326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alshammari MA, Alshammari TK, and Laezza F (2016). Improved Methods for Fluorescence Microscopy Detection of Macromolecules at the Axon Initial Segment. Front Cell Neurosci
10, 5. 10.3389/fncel.2016.00005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fncel.2016.00005</ArticleId>
            <ArticleId IdType="pmc">PMC4754416</ArticleId>
            <ArticleId IdType="pubmed">26909021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Azumaya CM, Days EL, Vinson PN, Stauffer S, Sulikowski G, Weaver CD, and Nakagawa T (2017). Screening for AMPA receptor auxiliary subunit specific modulators. PLoS One
12, e0174742. 10.1371/journal.pone.0174742.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0174742</ArticleId>
            <ArticleId IdType="pmc">PMC5373622</ArticleId>
            <ArticleId IdType="pubmed">28358902</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beenhakker MP, and Huguenard JR (2009). Neurons that fire together also conspire together: is normal sleep circuitry hijacked to generate epilepsy?
Neuron
62, 612–632. 10.1016/j.neuron.2009.05.015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuron.2009.05.015</ArticleId>
            <ArticleId IdType="pmc">PMC2748990</ArticleId>
            <ArticleId IdType="pubmed">19524522</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bender AC, Luikart BW, and Lenck-Santini PP (2016). Cognitive Deficits Associated with Nav1.1 Alterations: Involvement of Neuronal Firing Dynamics and Oscillations. PLoS One
11, e0151538. 10.1371/journal.pone.0151538.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0151538</ArticleId>
            <ArticleId IdType="pmc">PMC4792481</ArticleId>
            <ArticleId IdType="pubmed">26978272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bender AC, Natola H, Ndong C, Holmes GL, Scott RC, and Lenck-Santini PP (2013). Focal Scn1a knockdown induces cognitive impairment without seizures. Neurobiol Dis
54, 297–307. 10.1016/j.nbd.2012.12.021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.nbd.2012.12.021</ArticleId>
            <ArticleId IdType="pmc">PMC3628954</ArticleId>
            <ArticleId IdType="pubmed">23318929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berkvens JJ, Veugen I, Veendrick-Meekes MJ, Snoeijen-Schouwenaars FM, Schelhaas HJ, Willemsen MH, Tan IY, and Aldenkamp AP (2015). Autism and behavior in adult patients with Dravet syndrome (DS). Epilepsy Behav
47, 11–16. 10.1016/j.yebeh.2015.04.057.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yebeh.2015.04.057</ArticleId>
            <ArticleId IdType="pubmed">26005841</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brecht M, and Sakmann B (2002). Whisker maps of neuronal subclasses of the rat ventral posterior medial thalamus, identified by whole-cell voltage recording and morphological reconstruction. J Physiol
538, 495–515. 10.1113/jphysiol.2001.012334.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1113/jphysiol.2001.012334</ArticleId>
            <ArticleId IdType="pmc">PMC2290066</ArticleId>
            <ArticleId IdType="pubmed">11790815</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Castro-Alamancos MA (2002). Properties of primary sensory (lemniscal) synapses in the ventrobasal thalamus and the relay of high-frequency sensory inputs. J Neurophysiol
87, 946–953. 10.1152/jn.00426.2001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/jn.00426.2001</ArticleId>
            <ArticleId IdType="pubmed">11826059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Catarino CB, Liu JY, Liagkouras I, Gibbons VS, Labrum RW, Ellis R, Woodward C, Davis MB, Smith SJ, Cross JH, et al. (2011). Dravet syndrome as epileptic encephalopathy: evidence from long-term course and neuropathology. Brain
134, 2982–3010. 10.1093/brain/awr129.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/brain/awr129</ArticleId>
            <ArticleId IdType="pmc">PMC3187538</ArticleId>
            <ArticleId IdType="pubmed">21719429</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheong E, and Shin HS (2013). T-type Ca2+ channels in normal and abnormal brain functions. Physiol Rev
93, 961–992. 10.1152/physrev.00010.2012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/physrev.00010.2012</ArticleId>
            <ArticleId IdType="pubmed">23899559</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chiron C (2011). Current therapeutic procedures in Dravet syndrome. Dev Med Child Neurol
53 Suppl 2, 16–18. 10.1111/j.1469-8749.2011.03967.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1469-8749.2011.03967.x</ArticleId>
            <ArticleId IdType="pubmed">21504427</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Claes L, Del-Favero J, Ceulemans B, Lagae L, Van Broeckhoven C, and De Jonghe P (2001). De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet
68, 1327–1332. 10.1086/320609.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/320609</ArticleId>
            <ArticleId IdType="pmc">PMC1226119</ArticleId>
            <ArticleId IdType="pubmed">11359211</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clemente-Perez A, Makinson SR, Higashikubo B, Brovarney S, Cho FS, Urry A, Holden SS, Wimer M, David C, Fenno LE, et al. (2017). Distinct Thalamic Reticular Cell Types Differentially Modulate Normal and Pathological Cortical Rhythms. Cell Rep
19, 2130–2142. 10.1016/j.celrep.2017.05.044.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2017.05.044</ArticleId>
            <ArticleId IdType="pmc">PMC5557038</ArticleId>
            <ArticleId IdType="pubmed">28591583</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cross JH, Caraballo RH, Nabbout R, Vigevano F, Guerrini R, and Lagae L (2019). Dravet syndrome: Treatment options and management of prolonged seizures. Epilepsia
60 Suppl 3, S39–S48. 10.1111/epi.16334.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/epi.16334</ArticleId>
            <ArticleId IdType="pubmed">31904119</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Darra F, Battaglia D, Dravet C, Patrini M, Offredi F, Chieffo D, Piazza E, Fontana E, Olivieri G, Turrini I, et al. (2019). Dravet syndrome: Early electroclinical findings and long-term outcome in adolescents and adults. Epilepsia
60 Suppl 3, S49–S58. 10.1111/epi.16297.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/epi.16297</ArticleId>
            <ArticleId IdType="pubmed">31904122</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deleuze C, and Huguenard J (2016). Two classes of excitatory synaptic responses in rat thalamic reticular neurons. J Neurophysiol
116, 995–1011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5009213</ArticleId>
            <ArticleId IdType="pubmed">27281752</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dravet C (2011). The core Dravet syndrome phenotype. Epilepsia
52 Suppl 2, 3–9. 10.1111/j.1528-1167.2011.02994.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1528-1167.2011.02994.x</ArticleId>
            <ArticleId IdType="pubmed">21463272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Favero M, Sotuyo NP, Lopez E, Kearney JA, and Goldberg EM (2018). A Transient Developmental Window of Fast-Spiking Interneuron Dysfunction in a Mouse Model of Dravet Syndrome. J Neurosci
38, 7912–7927. 10.1523/JNEUROSCI.0193-18.2018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.0193-18.2018</ArticleId>
            <ArticleId IdType="pmc">PMC6125809</ArticleId>
            <ArticleId IdType="pubmed">30104343</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fernandez LMJ, and Luthi A (2020). Sleep Spindles: Mechanisms and Functions. Physiol Rev
100, 805–868. 10.1152/physrev.00042.2018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/physrev.00042.2018</ArticleId>
            <ArticleId IdType="pubmed">31804897</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fogerson PM, and Huguenard JR (2016). Tapping the Brakes: Cellular and Synaptic Mechanisms that Regulate Thalamic Oscillations. Neuron
92, 687–704. 10.1016/j.neuron.2016.10.024.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuron.2016.10.024</ArticleId>
            <ArticleId IdType="pmc">PMC5131525</ArticleId>
            <ArticleId IdType="pubmed">27883901</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gataullina S, and Dulac O (2017). From genotype to phenotype in Dravet disease. Seizure
44, 58–64. 10.1016/j.seizure.2016.10.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.seizure.2016.10.014</ArticleId>
            <ArticleId IdType="pubmed">27817982</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Graziano A, Liu X-B, Murray KD, and Jones EG (2008). Vesicular Glutamate Transporters Define Two Sets of Glutamatergic Afferents to the Somatosensory Thalamus and Two Thalamocortical Projections in the Mouse. The Journal of Comparative Neurology
507, 1258–1276.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18181146</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hains BC, Saab CY, and Waxman SG (2006). Alterations in burst firing of thalamic VPL neurons and reversal by Na(v)1.3 antisense after spinal cord injury. J Neurophysiol
95, 3343–3352. 10.1152/jn.01009.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/jn.01009.2005</ArticleId>
            <ArticleId IdType="pubmed">16481457</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Han S, Tai C, Westenbroek RE, Yu FH, Cheah CS, Potter GB, Rubenstein JL, Scheuer T, de la Iglesia HO, and Catterall WA (2012). Autistic-like behaviour in Scn1a+/− mice and rescue by enhanced GABA-mediated neurotransmission. Nature
489, 385–390. 10.1038/nature11356.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature11356</ArticleId>
            <ArticleId IdType="pmc">PMC3448848</ArticleId>
            <ArticleId IdType="pubmed">22914087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hansen KB, Yi F, Perszyk RE, Furukawa H, Wollmuth LP, Gibb AJ, and Traynelis SF (2018). Structure, function, and allosteric modulation of NMDA receptors. J Gen Physiol
150, 1081–1105. 10.1085/jgp.201812032.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1085/jgp.201812032</ArticleId>
            <ArticleId IdType="pmc">PMC6080888</ArticleId>
            <ArticleId IdType="pubmed">30037851</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hanson JE, Ma K, Elstrott J, Weber M, Saillet S, Khan AS, Simms J, Liu B, Kim TA, Yu GQ, et al. (2020). GluN2A NMDA Receptor Enhancement Improves Brain Oscillations, Synchrony, and Cognitive Functions in Dravet Syndrome and Alzheimer’s Disease Models. Cell Rep
30, 381–396
 e384. 10.1016/j.celrep.2019.12.030.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2019.12.030</ArticleId>
            <ArticleId IdType="pmc">PMC7017907</ArticleId>
            <ArticleId IdType="pubmed">31940483</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hedrich UB, Liautard C, Kirschenbaum D, Pofahl M, Lavigne J, Liu Y, Theiss S, Slotta J, Escayg A, Dihne M, et al. (2014). Impaired action potential initiation in GABAergic interneurons causes hyperexcitable networks in an epileptic mouse model carrying a human Na(V)1.1 mutation. J Neurosci
34, 14874–14889. 10.1523/JNEUROSCI.0721-14.2014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.0721-14.2014</ArticleId>
            <ArticleId IdType="pmc">PMC4220023</ArticleId>
            <ArticleId IdType="pubmed">25378155</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Henderson LA, Peck CC, Petersen ET, Rae CD, Youssef AM, Reeves JM, Wilcox SL, Akhter R, Murray GM, and Gustin SM (2013). Chronic pain: lost inhibition?
J Neurosci
33, 7574–7582. 10.1523/JNEUROSCI.0174-13.2013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.0174-13.2013</ArticleId>
            <ArticleId IdType="pmc">PMC6619566</ArticleId>
            <ArticleId IdType="pubmed">23616562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hovelso N, Sotty F, Montezinho LP, Pinheiro PS, Herrik KF, and Mork A (2012). Therapeutic potential of metabotropic glutamate receptor modulators. Curr Neuropharmacol
10, 12–48. 10.2174/157015912799362805.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/157015912799362805</ArticleId>
            <ArticleId IdType="pmc">PMC3286844</ArticleId>
            <ArticleId IdType="pubmed">22942876</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kadriu B, Musazzi L, Johnston JN, Kalynchuk LE, Caruncho HJ, Popoli M, and Zarate CA Jr. (2021). Positive AMPA receptor modulation in the treatment of neuropsychiatric disorders: A long and winding road. Drug Discov Today. 10.1016/j.drudis.2021.07.027.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.drudis.2021.07.027</ArticleId>
            <ArticleId IdType="pubmed">34358693</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalume F, Oakley JC, Westenbroek RE, Gile J, de la Iglesia HO, Scheuer T, and Catterall WA (2015). Sleep impairment and reduced interneuron excitability in a mouse model of Dravet Syndrome. Neurobiol Dis
77, 141–154. 10.1016/j.nbd.2015.02.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.nbd.2015.02.016</ArticleId>
            <ArticleId IdType="pmc">PMC4402280</ArticleId>
            <ArticleId IdType="pubmed">25766678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalume F, Yu FH, Westenbroek RE, Scheuer T, and Catterall WA (2007). Reduced sodium current in Purkinje neurons from Nav1.1 mutant mice: implications for ataxia in severe myoclonic epilepsy in infancy. J Neurosci
27, 11065–11074. 10.1523/JNEUROSCI.2162-07.2007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.2162-07.2007</ArticleId>
            <ArticleId IdType="pmc">PMC6672849</ArticleId>
            <ArticleId IdType="pubmed">17928448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khatri A, Burger PB, Swanger SA, Hansen KB, Zimmerman S, Karakas E, Liotta DC, Furukawa H, Snyder JP, and Traynelis SF (2014). Structural determinants and mechanism of action of a GluN2C-selective NMDA receptor positive allosteric modulator. Mol Pharmacol
86, 548–560. 10.1124/mol.114.094516.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1124/mol.114.094516</ArticleId>
            <ArticleId IdType="pmc">PMC4201136</ArticleId>
            <ArticleId IdType="pubmed">25205677</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Landisman J.S.H.a.C.E. (2012). State-dependent modulation of gap junction signaling by the persistent sodium current. Frontiers in Cellular Neuroscience
5 (31).</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3263475</ArticleId>
            <ArticleId IdType="pubmed">22319469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Layer N, Sonnenberg L, Gonzalez EP, Benda J, Hedrich UBS, Lerche H, Koch H, and Wuttke TV (2021). Dravet Variant SCN1AA1783V Impairs Interneuron Firing Predominantly by Altered Channel Activation. Frontiers in Cellular Neuroscience
15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8581729</ArticleId>
            <ArticleId IdType="pubmed">34776868</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee J, Kim D, and Shin HS (2004). Lack of delta waves and sleep disturbances during non-rapid eye movement sleep in mice lacking alpha1G-subunit of T-type calcium channels. Proc Natl Acad Sci U S A
101, 18195–18199. 10.1073/pnas.0408089101.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0408089101</ArticleId>
            <ArticleId IdType="pmc">PMC539778</ArticleId>
            <ArticleId IdType="pubmed">15601764</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lenz FA (1992). The ventral posterior nucleus of thalamus is involved in the generation of central pain syndromes. APS Journal
1, 42–51. 10.1016/S1058-9139(06)80011-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1058-9139(06)80011-2</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Y, Lopez-Huerta VG, Adiconis X, Levandowski K, Choi S, Simmons SK, Arias-Garcia MA, Guo B, Yao AY, Blosser TR, et al. (2020). Distinct subnetworks of the thalamic reticular nuclues. Nature
583, 819–824.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7394718</ArticleId>
            <ArticleId IdType="pubmed">32699411</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Licheni SH, McMahon JM, Schneider AL, Davey MJ, and Scheffer IE (2018). Sleep problems in Dravet syndrome: a modifiable comorbidity. Dev Med Child Neurol
60, 192–198. 10.1111/dmcn.13601.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/dmcn.13601</ArticleId>
            <ArticleId IdType="pubmed">29110313</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu J, Shelkar GP, Zhao F, Clausen RP, and Dravid SM (2019). Modulation of burst firing of neurons in nucleus reticularis of the thalamus by GluN2C-containing NMDA receptors. Mol Pharmacol. 10.1124/mol.119.116780.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1124/mol.119.116780</ArticleId>
            <ArticleId IdType="pmc">PMC6620419</ArticleId>
            <ArticleId IdType="pubmed">31160332</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martinez-Garcia RI, Voelcker B, Zaltsman J, Patrick S, Stevens T, Conners B, and Cruikshank S (2020). Two dynamically distinct circuits driving inhibition in sensory thalamus. bioRxiv.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7394732</ArticleId>
            <ArticleId IdType="pubmed">32699410</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mazzitelli M, Palazzo E, Maione S, and Neugebauer V (2018). Group II Metabotropic Glutamate Receptors: Role in Pain Mechanisms and Pain Modulation. Front Mol Neurosci
11, 383. 10.3389/fnmol.2018.00383.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnmol.2018.00383</ArticleId>
            <ArticleId IdType="pmc">PMC6189308</ArticleId>
            <ArticleId IdType="pubmed">30356691</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCafferty C, David F, Venzi M, Lorincz ML, Delicata F, Atherton Z, Recchia G, Orban G, Lambert RC, Di Giovanni G, et al. (2018). Cortical drive and thalamic feed-forward inhibition control thalamic output synchrony during absence seizures. Nat Neurosci
21, 744–756. 10.1038/s41593-018-0130-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41593-018-0130-4</ArticleId>
            <ArticleId IdType="pmc">PMC6278913</ArticleId>
            <ArticleId IdType="pubmed">29662216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCormick DA, and von Krosigk M (1992). Corticothalamic activation modulates thalamic firing through glutamate “metabotropic” receptors. Proc Natl Acad Sci U S A
89, 2774–2778. 10.1073/pnas.89.7.2774.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.89.7.2774</ArticleId>
            <ArticleId IdType="pmc">PMC48745</ArticleId>
            <ArticleId IdType="pubmed">1313567</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miller AR, Hawkins NA, McCollom CE, and Kearney JA (2014). Mapping genetic modifiers of survival in a mouse model of Dravet syndrome. Genes Brain Behav
13, 163–172. 10.1111/gbb.12099.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/gbb.12099</ArticleId>
            <ArticleId IdType="pmc">PMC3930200</ArticleId>
            <ArticleId IdType="pubmed">24152123</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miyata M, and Imoto K (2006). Different composition of glutamate receptors in corticothalamic and lemniscal synaptic responses and their roles in the firing responses of ventrobasal thalamic neurons in juvenile mice. J Physiol
575, 161–174. 10.1113/jphysiol.2006.114413.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1113/jphysiol.2006.114413</ArticleId>
            <ArticleId IdType="pmc">PMC1819410</ArticleId>
            <ArticleId IdType="pubmed">16777934</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moehring J, von Spiczak S, Moeller F, Helbig I, Wolff S, Jansen O, Muhle H, Boor R, Stephani U, and Siniatchkin M (2013). Variability of EEG-fMRI findings in patients with SCN1A-positive Dravet syndrome. Epilepsia
54, 918–926. 10.1111/epi.12119.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/epi.12119</ArticleId>
            <ArticleId IdType="pubmed">23398550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mullasseril P, Hansen KB, Vance KM, Ogden KK, Yuan H, Kurtkaya NL, Santangelo R, Orr AG, Le P, Vellano KM, et al. (2010). A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors. Nat Commun
1, 90. 10.1038/ncomms1085.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncomms1085</ArticleId>
            <ArticleId IdType="pmc">PMC3113701</ArticleId>
            <ArticleId IdType="pubmed">20981015</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ogiwara I, Iwasato T, Miyamoto H, Iwata R, Yamagata T, Mazaki E, Yanagawa Y, Tamamaki N, Hensch TK, Itohara S, and Yamakawa K (2013). Nav1.1 haploinsufficiency in excitatory neurons ameliorates seizure-associated sudden death in a mouse model of Dravet syndrome. Hum Mol Genet
22, 4784–4804. 10.1093/hmg/ddt331.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddt331</ArticleId>
            <ArticleId IdType="pmc">PMC3820136</ArticleId>
            <ArticleId IdType="pubmed">23922229</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ogiwara I, Miyamoto H, Morita N, Atapour N, Mazaki E, Inoue I, Takeuchi T, Itohara S, Yanagawa Y, Obata K, et al. (2007). Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation. J Neurosci
27, 5903–5914. 10.1523/JNEUROSCI.5270-06.2007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.5270-06.2007</ArticleId>
            <ArticleId IdType="pmc">PMC6672241</ArticleId>
            <ArticleId IdType="pubmed">17537961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Papale LA, Makinson CD, Christopher Ehlen J, Tufik S, Decker MJ, Paul KN, and Escayg A (2013). Altered sleep regulation in a mouse model of SCN1A-derived genetic epilepsy with febrile seizures plus (GEFS+). Epilepsia
54, 625–634. 10.1111/epi.12060.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/epi.12060</ArticleId>
            <ArticleId IdType="pmc">PMC3703918</ArticleId>
            <ArticleId IdType="pubmed">23311867</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parri RH, and Crunelli V (1998). Sodium current in rat and cat thalamocortical neurons: role of a non-inactivating component in tonic and burst firing. J Neuroscience
18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6792749</ArticleId>
            <ArticleId IdType="pubmed">9437007</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ragona F (2011). Cognitive development in children with Dravet syndrome. Epilepsia
52 Suppl 2, 39–43. 10.1111/j.1528-1167.2011.03000.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1528-1167.2011.03000.x</ArticleId>
            <ArticleId IdType="pubmed">21463278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ritter-Makinson S, Clemente-Perez A, Higashikubo B, Cho FS, Holden SS, Bennett E, Chkhaidze A, Eelkman Rooda OHJ, Cornet MC, Hoebeek FE, et al. (2019). Augmented Reticular Thalamic Bursting and Seizures in Scn1a-Dravet Syndrome. Cell Rep
26, 54–64
 e56. 10.1016/j.celrep.2018.12.018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2018.12.018</ArticleId>
            <ArticleId IdType="pmc">PMC6555418</ArticleId>
            <ArticleId IdType="pubmed">30605686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodda JM, Scheffer IE, McMahon JM, Berkovic SF, and Graham HK (2012). Progressive gait deterioration in adolescents with Dravet syndrome. Arch Neurol
69, 873–878. 10.1001/archneurol.2011.3275.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archneurol.2011.3275</ArticleId>
            <ArticleId IdType="pubmed">22409937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rubinstein M, Han S, Tai C, Westenbroek RE, Hunker A, Scheuer T, and Catterall WA (2015a). Dissecting the phenotypes of Dravet syndrome by gene deletion. Brain
138, 2219–2233. 10.1093/brain/awv142.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/brain/awv142</ArticleId>
            <ArticleId IdType="pmc">PMC5022661</ArticleId>
            <ArticleId IdType="pubmed">26017580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rubinstein M, Westenbroek RE, Yu FH, Jones CJ, Scheuer T, and Catterall WA (2015b). Genetic background modulates impaired excitability of inhibitory neurons in a mouse model of Dravet syndrome. Neurobiol Dis
73, 106–117. 10.1016/j.nbd.2014.09.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.nbd.2014.09.017</ArticleId>
            <ArticleId IdType="pmc">PMC4254180</ArticleId>
            <ArticleId IdType="pubmed">25281316</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crandall Shane R., C. S, Connors Barry (2015). A Corticothalamic Switch: Controlling the Thalamus with Dynamic Switches. Neuron
86, 768–782.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4425600</ArticleId>
            <ArticleId IdType="pubmed">25913856</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sherman SM (2001). Tonic and burst firing: dual modes of thalamocortical relay. Trends Neurosci
24, 122–126. 10.1016/s0166-2236(00)01714-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0166-2236(00)01714-8</ArticleId>
            <ArticleId IdType="pubmed">11164943</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stafstrom CE (2007). Persistent Sodium Current and Its Role in Epilepsy. Current Review in Basic Science
7, 15–22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1797888</ArticleId>
            <ArticleId IdType="pubmed">17304346</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Steriade M, and Llinas RR (1988). The functional states of the thalamus and the associated neuronal interplay. Physiol Rev
68, 649–742. 10.1152/physrev.1988.68.3.649.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/physrev.1988.68.3.649</ArticleId>
            <ArticleId IdType="pubmed">2839857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Swanger SA, Vance KM, Acker TM, Zimmerman SS, DiRaddo JO, Myers SJ, Bundgaard C, Mosley CA, Summer SL, Menaldino DS, et al. (2018). A Novel Negative Allosteric Modulator Selective for GluN2C/2D-Containing NMDA Receptors Inhibits Synaptic Transmission in Hippocampal Interneurons. ACS Chem Neurosci
9, 306–319. 10.1021/acschemneuro.7b00329.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acschemneuro.7b00329</ArticleId>
            <ArticleId IdType="pmc">PMC5924706</ArticleId>
            <ArticleId IdType="pubmed">29043770</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tai C, Abe Y, Westenbroek RE, Scheuer T, and Catterall WA (2014). Impaired excitability of somatostatin- and parvalbumin-expressing cortical interneurons in a mouse model of Dravet syndrome. Proc Natl Acad Sci U S A
111, E3139–3148. 10.1073/pnas.1411131111.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1411131111</ArticleId>
            <ArticleId IdType="pmc">PMC4121787</ArticleId>
            <ArticleId IdType="pubmed">25024183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takayama R, Fujiwara T, Shigematsu H, Imai K, Takahashi Y, Yamakawa K, and Inoue Y (2014). Long-term course of Dravet syndrome: a study from an epilepsy center in Japan. Epilepsia
55, 528–538. 10.1111/epi.12532.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/epi.12532</ArticleId>
            <ArticleId IdType="pubmed">24502503</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Temereanca S, S. D (2004). Functional topography of corticothalamic feedback enhances thalamic spatial response tuning in the somatosensory whisker/barrel system. Neuron
41, 639–651.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14980211</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Villas N, Meskis MA, and Goodliffe S (2017). Dravet syndrome: Characteristics, comorbidities, and caregiver concerns. Epilepsy Behav
74, 81–86. 10.1016/j.yebeh.2017.06.031.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yebeh.2017.06.031</ArticleId>
            <ArticleId IdType="pubmed">28732259</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolff M, and Vann SD (2019). The Cognitive Thalamus as a Gateway to Mental Representations. J Neurosci
39, 3–14. 10.1523/JNEUROSCI.0479-18.2018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.0479-18.2018</ArticleId>
            <ArticleId IdType="pmc">PMC6325267</ArticleId>
            <ArticleId IdType="pubmed">30389839</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yi F, Rouzbeh N, Hansen KB, Xu Y, Fanger CM, Gordon E, Paschetto K, Menniti FS, and Volkmann RA (2020). PTC-174, a positive allosteric modulator of NMDA receptors containing GluN2C or GluN2D subunits. Neuropharmacology
173, 107971. 10.1016/j.neuropharm.2020.107971.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuropharm.2020.107971</ArticleId>
            <ArticleId IdType="pmc">PMC7293934</ArticleId>
            <ArticleId IdType="pubmed">31987864</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao P, Waxman SG, and Hains BC (2006). Sodium channel expression in the ventral posterolateral nucleus of the thalamus after peripheral nerve injury. Mol Pain
2, 27. 10.1186/1744-8069-2-27.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1744-8069-2-27</ArticleId>
            <ArticleId IdType="pmc">PMC1563449</ArticleId>
            <ArticleId IdType="pubmed">16916452</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zikopoulos B, and Barbas H (2006). Prefrontal projections to the thalamic reticular nucleus form a unique circuit for attentional mechanisms. J Neurosci
26, 7348–7361. 10.1523/JNEUROSCI.5511-05.2006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.5511-05.2006</ArticleId>
            <ArticleId IdType="pmc">PMC6674204</ArticleId>
            <ArticleId IdType="pubmed">16837581</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
